Summary:
- The article discusses a Cambridge University spinout company called Benevolent AI that is using AI technology to find new treatments for heart disease, which is the world's biggest killer.
- Benevolent AI's AI system is able to analyze vast amounts of data on heart disease and potential treatments, identifying new drug targets and repurposing existing drugs that could be effective against heart disease.
- The company has already had some promising results, with its AI-discovered drug candidates entering clinical trials, and it is aiming to accelerate the drug discovery process and bring new treatments to market more quickly.